EMA Authorised: Capecitabine Teva (capecitabine) — Teva Pharma B.V.

View source ↗

Summary

EMA authorised Capecitabine Teva (capecitabine), a generic capecitabine product by Teva Pharma B.V., for multiple cancer indications, including breast, colorect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms
• Colonic Neoplasms
• Colorectal Neoplasms
• Stomach Neoplasms

Drugs mentioned

• Capecitabine Teva (capecitabine)

Snippet

Status: Authorised. Therapeutic area: Colonic Neoplasms;Breast Neoplasms;Colorectal Neoplasms;Stomach Neoplasms. MAH: Teva Pharma B.V.. Decision date: 10/07/2025